Insiders · GH

Steve E. Krognes

Director at Guardant Health, Inc. (GH) since June 2022

Steve E. Krognes has filed 89 insider reports with the SEC since January 2021, as director at Guardant Health, Inc. (GH), director at Pliant Therapeutics, Inc. (PLRX) and director at Denali Therapeutics Inc. (DNLI) and at 1 more company. In the last 12 months Steve E. Krognes sold $2.4M of stock on the open market. In the latest filing, on September 17, 2026, Steve E. Krognes sold 6,674 shares of Guardant Health, Inc. (GH) for $1.17M at an average of $175.74.

Filings
89
Companies
4
Bought on market
None
Sold on market
$17.6M

Companies where Steve E. Krognes is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Guardant Health, Inc. logo
GH
Guardant Health, Inc.
Directorsince June 20227,906$2.4M$151.70Sep 17, 2026
Pliant Therapeutics, Inc. logo
PLRX
Pliant Therapeutics, Inc.
Directorsince June 2024$0.697Jun 12, 2026
Denali Therapeutics Inc. logo
DNLI
Denali Therapeutics Inc.
Director38,202$15.2M$18.74Jun 5, 2026
Gritstone bio, Inc. logo
GRTS
Gritstone bio, Inc.
DirectorJun 21, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Steve E. Krognes with

Other insiders at the same companies

Questions about Steve E. Krognes

What is Steve E. Krognes's role at Guardant Health, Inc.?
Steve E. Krognes reports to the SEC as director at Guardant Health, Inc. (GH), according to the latest filing on September 17, 2026. Steve E. Krognes has also filed as director at Pliant Therapeutics, Inc. (PLRX), director at Denali Therapeutics Inc. (DNLI) and director at Gritstone bio, Inc. (GRTS).
How many shares does Steve E. Krognes own?
After the latest filing that states it, Steve E. Krognes directly owned 7,906 shares of Guardant Health, Inc. (GH) and 38,202 shares of Denali Therapeutics Inc. (DNLI). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Steve E. Krognes bought or sold stock recently?
The most recent open-market sale was on September 16, 2026: sold 6,674 shares of Guardant Health, Inc. (GH) for $1.17M at an average of $175.74.
How do I get alerts when Steve E. Krognes files?
Follow Steve E. Krognes on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Steve E. Krognes filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Steve E. Krognes (SEC CIK 0001666236). Totals count each trade once, skipping amendments whose original is on file, from Jan 20, 2021 on. View on SEC EDGAR